Linical is a global speciality CRO headquartered in Osaka, Japan, listed in the prime segment of the Tokyo Stock exchange, and dedicated to serve its clients as a true partner in development. With more than 900 employees Linical directly covers more than 20 countries and all key markets in Asia-Pacific, Japan, Europe and N. America via its own offices.

As a premium CRO and being recognized as the quality leader, we focus on the therapeutic areas oncology, immunology,  respiratory and allergy, endocrinology, GI and CNS based on experience and expertise.